Publications by authors named "Leah M Flick"

Barcoding viable cells combined with pooled sample staining is an effective technique that eliminates batch effects from serial cell staining and facilitates uninterrupted data acquisition. We describe three novel and isotopically pure selenium-containing compounds (SeMals) that are useful cellular labeling tools. The maleimide-functionalized selenophenes (SeMal, SeMal, and SeMal) covalently react with cellular sulfhydryl groups and uniquely label cell samples.

View Article and Find Full Text PDF
Article Synopsis
  • - Neoadjuvant chemotherapy using cisplatin is the typical treatment for serious bladder cancer, and combining it with immune therapy has shown good results in some patients.
  • - In a trial called LCCC1520, 22 out of 39 patients with muscle-invasive bladder cancer improved after receiving a treatment that combined chemotherapy and an immune drug.
  • - Scientists found that certain markers in blood and tumors could help predict which patients will respond well to this combined treatment, suggesting ways to tailor care for better outcomes.
View Article and Find Full Text PDF

Human natural killer T cells (NKTs) are innate-like T lymphocytes increasingly used for cancer immunotherapy. Here we show that human NKTs expressing the pro-inflammatory cytokine interleukin-12 (IL-12) undergo extensive and sustained molecular and functional reprogramming. Specifically, IL-12 instructs and maintains a Th1-polarization program in NKTs in vivo without causing their functional exhaustion.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of B cell activating factor (BAFF) in regulating weight homeostasis and its effects on obesity resistance in mice.
  • Overexpression of BAFF leads to protection against weight gain by promoting lipid metabolism and enhancing energy expenditure in both white and brown adipose tissues.
  • Genetic deletion of BAFF and its homolog APRIL results in increased obesity, and these findings are relevant to human adipocytes, with higher levels of BAFF/APRIL linked to reduced BMI post-bariatric surgery.
View Article and Find Full Text PDF
Article Synopsis
  • Inflammation is a key factor in obesity-related health issues, particularly in the development of nonalcoholic fatty liver disease (NAFLD), which is now the most common chronic liver disease in developed countries.
  • Research shows that mice lacking IL-17RA experienced more weight gain and fat accumulation when on a high-fat diet but had less liver damage compared to normal mice, suggesting a complex relationship between obesity and liver health.
  • The study concludes that the IL-17 signaling pathway plays a crucial role in the worsening of NAFLD and could be a promising target for new treatments.
View Article and Find Full Text PDF

Alterations in the gut microbiota have been proposed to modify the development and maintenance of obesity and its sequelae. Definition of underlying mechanisms has lagged, although the ability of commensal gut microbes to drive pathways involved in inflammation and metabolism has generated compelling, testable hypotheses. We studied C57BL/6 mice from two vendors that differ in their obesogenic response and in their colonization by specific members of the gut microbiota having well-described roles in regulating gut immune responses.

View Article and Find Full Text PDF
Article Synopsis
  • CYP1 monooxygenases are involved in the biosynthesis and inactivation of lipid mediators, but their specific metabolic roles are not fully understood. Researchers used advanced techniques to analyze lipid mediator profiles in knockout mice lacking CYP1 genes compared to wild-type mice.
  • In the absence of CYP1 enzymes, no significant differences in untreated mice were observed regarding cell counts or CYP1 activity; however, during inflammation induced by zymosan, knockout mice displayed increased neutrophil recruitment and altered levels of various lipid mediators.
  • The study found significant changes in the metabolomic profiles of lipid mediators due to zymosan stimulation, revealing that CYP1 enzymes play a critical role in regulating these mediators and influencing
View Article and Find Full Text PDF

Mechanistic understanding of RP105 has been confounded by the fact that this TLR homolog has appeared to have opposing, cell type-specific effects on TLR4 signaling. Although RP105 inhibits TLR4-driven signaling in cell lines and myeloid cells, impaired LPS-driven proliferation by B cells from RP105(-/-) mice has suggested that RP105 facilitates TLR4 signaling in B cells. In this article, we show that modulation of B cell proliferation by RP105 is not a function of B cell-intrinsic expression of RP105, and identify a mechanistic role for dysregulated BAFF expression in the proliferative abnormalities of B cells from RP105(-/-) mice: serum BAFF levels are elevated in RP105(-/-) mice, and partial BAFF neutralization rescues aberrant B cell proliferative responses in such mice.

View Article and Find Full Text PDF

Lung disease is the major cause of morbidity and mortality in cystic fibrosis, an autosomal recessive disease caused by mutations in CFTR. In cystic fibrosis, chronic infection and dysregulated neutrophilic inflammation lead to progressive airway destruction. The severity of cystic fibrosis lung disease has considerable heritability, independent of CFTR genotype.

View Article and Find Full Text PDF
Article Synopsis
  • Immune responses can be damaging if not properly regulated, so it's crucial to control their strength, timing, and nature to maintain health.
  • After initial research on how certain receptors (like TLRs and NLRs) activate immune responses, a second wave of studies has focused on understanding how these signals are kept in check.
  • This overview discusses the RP105/MD-1 complex, which helps modulate TLR4, one of the strongest signaling TLRs, highlighting current knowledge and debates in the field.
View Article and Find Full Text PDF

Dysregulated neutrophilic inflammation and chronic infection lead to progressive destruction of the airways in cystic fibrosis (CF). Despite considerable recent progress in therapy, the median survival of patients with CF remains around 30 years. The lipoxins are endogenous anti-inflammatory lipid mediators that are important regulators of neutrophilic inflammation.

View Article and Find Full Text PDF
Article Synopsis
  • Cystic fibrosis causes severe airway damage due to uncontrolled neutrophil inflammation and chronic infections, but the exact mechanisms are not fully understood.
  • Research indicates that lipoxins, which normally help reduce inflammation, are significantly lower in the airway fluid of cystic fibrosis patients compared to those with other lung issues.
  • A study using a stable lipoxin analog in mice showed reduced inflammation and bacterial levels in the lungs, suggesting that enhancing lipoxin activity could be a promising treatment for cystic fibrosis.
View Article and Find Full Text PDF